GHK-Cu

Overview

GHK-Cu is a naturally occurring copper-peptide complex consisting of three amino acids (glycine, histidine, and lysine) coordinated with cupric ion (Cu²⁺). This tripeptide-copper complex was first identified and characterized by Dr. Loren Pickart in 1973 and occurs naturally in human blood plasma, saliva, and urine. GHK-Cu is identified by CAS number 49557-74-6 and exists as a blue lyophilized powder. The compound is supplied exclusively for laboratory research applications. Notably, circulating GHK-Cu concentrations decline significantly with age, making it a subject of intense research interest.

Research Background

Over three decades of peer-reviewed research has established GHK-Cu as one of the most thoroughly investigated peptide-metal complexes. With over 30 peer-reviewed publications documenting its biological activities, GHK-Cu has become central to understanding peptide-based tissue remodeling and longevity research.

Key Research Areas:

• Wound Healing: Research indicates GHK-Cu accelerates wound closure through multiple pathways including enhanced collagen synthesis and angiogenesis, as documented in numerous studies.
• Skin Remodeling and Collagen Synthesis: Studies suggest GHK-Cu stimulates fibroblast activity and collagen deposition, supporting skin structural integrity and elasticity. Research published in dermatological journals documents enhanced dermal thickness and collagen organization.
• Anti-Aging Research: A landmark study by the Broad Institute documented that GHK-Cu shifts expression patterns of over 1,700 genes toward patterns characteristic of younger skin cells, making it highly relevant to aging research.
• Antioxidant Activity: Research indicates GHK-Cu acts as a superoxide dismutase (SOD) mimetic, enhancing cellular antioxidant capacity and reducing reactive oxygen species (ROS) by approximately 40% in preclinical models.
• Hair Growth Stimulation: Multiple studies document GHK-Cu's effects on hair follicle growth phases and hair growth rate enhancement in preclinical research.
• Bone Regeneration: Research indicates GHK-Cu supports osteoblast activity and bone matrix deposition, relevant to bone repair and regeneration studies.
• Gene Expression Modulation: The Broad Institute study noted that GHK-Cu modulates expression of genes involved in collagen synthesis, fibroblast function, and tissue repair, with transcriptional shifts consistent with tissue rejuvenation.

Mechanism of Action

GHK-Cu exerts its biological effects through multiple interconnected mechanisms:

• Copper Delivery System: The peptide complex serves as a bioavailable copper transporter, facilitating cellular copper uptake critical for numerous oxidative enzymes including cytochrome c oxidase, tyrosinase, and lysyl oxidase.
• Matrix Metalloproteinase (MMP) Activation: Research indicates GHK-Cu activates MMPs in a controlled manner, promoting selective breakdown and remodeling of extracellular matrix components—essential for tissue repair and remodeling.
• TGF-β Signaling Modulation: GHK-Cu research suggests modulation of transforming growth factor-beta signaling, a critical pathway in wound healing, fibrosis, and tissue development.
• Stem Cell Recruitment: Research indicates GHK-Cu promotes recruitment of bone marrow-derived stem cells through upregulation of stromal cell-derived factor-1 (SDF-1α) and vascular endothelial growth factor (VEGF).
• SOD Mimetic Activity: GHK-Cu functions as a superoxide dismutase mimetic, catalyzing conversion of superoxide radicals to hydrogen peroxide and oxygen. Research documents approximately 40% reduction in reactive oxygen species in preclinical models.
• Gene Expression Modulation: The complex modulates expression of genes involved in collagen synthesis, fibroblast differentiation, and tissue repair processes.

Specifications